首页> 外文会议>International symposium on controlled release of bioactive materials;Consumer and diversified products conference >Optimization of a controlled release intravaginal drug delivery system containing progesterone for the control of estrus in cattle
【24h】

Optimization of a controlled release intravaginal drug delivery system containing progesterone for the control of estrus in cattle

机译:含黄体酮的控释阴道内给药系统的优化,用于控制牛的发情期

获取原文

摘要

The CIDR-B insert~(TM) is an intravaginal insert with a surface area of 120cm~2 containing 10percent w/w progresterone (P4) in a silicone matrix (skin) moulded over a performed nylon spine (Fig. 1). Originally developed for 12d insertion periods, it has now been optimized for 7d insertion periods to meet the requirements of modern synchrony programs. This paper reports on the process by which the CIDR-B insert was optimized. The criteria which the optimized product was to meet were; a reduction in initial P4 content, reduction in residual P4 content and the deli8very of sufficient P4 such that plasma profiles were at least equivalent to the existing insert.
机译:CIDR-B插入物TM是一种阴道内插入物,其表面积为120cm 2,其中硅酮基质(皮肤)中的10%w / w孕酮(P4)在成型的尼龙脊柱上模制(图1)。最初为12d插入周期开发,现在已针对7d插入周期进行了优化,以满足现代同步程序的要求。本文报告了优化CIDR-B插入件的过程。优化产品要满足的标准是:降低了初始P4含量,减少了残余P4含量以及提供了足够的P4,使得血浆分布至少与现有插入物相同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号